Remove 2020 Remove IPO Remove Portfolio
article thumbnail

Covid-19 and US Venture Capital in 2020

InvestmentBank.com

One could likely dedicate an entire history book to all that has happened in 2020. This new world has forced many new adaptations and innovations, but what has this meant for those in VC who circled themselves around new trends and innovations long before 2020? According to analysis from PwC and CB Insights, Q2 2020 showed a 9.6%

Capital 40
article thumbnail

HKEX’s chief executive to step down with new succession plans in place

The TRADE

Chan joined HKEX as head of listing in January 2020 and currently serves as co-chief operating officer of HKEX. Before joining HKEX, she was a partner of Davis Polk & Wardwell from 2010 to 2019, where she oversaw a wide portfolio of clients in Hong Kong and across Asia.

IPO 116
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cooley’s 2020 Life Sciences M&A Year in Review

Cooley M&A

If 2019 was the year of life sciences mega-deals, 2020 was the year of COVID-19, as the global pandemic permeated every aspect of the dealmaking landscape, with the life sciences sector being no exception. Also impacted was Thermo Fisher’s attempted acquisition of Qiagen through a tender offer launched on March 3, 2020.

M&A 40
article thumbnail

“Dumb Money” Review: A Worthy Addition to the Classic Finance Movie Roster?

Mergers and Inquisitions

I’ll cover all those points here, but I want to start with some context first: A Long Time Ago in a Stock Market Far, Far Away To understand the premise of Dumb Money , you need to return to late 2020 and early 2021, which now seem like a lifetime ago: There was a global pandemic. I wrote many articles about it. Dumb Money has none of this.

Finance 105
article thumbnail

08-20-2023 Newsletter: Sunday Reading

OfficeHours

Once improved, the exit can then take place, usually in the form of another sale or an Initial Public Offering (IPO), both of which are usually under the advice of an investment bank. You must be able to consider long-term goals, assess risk, and craft plans to enhance the value of portfolio companies.

article thumbnail

Transfer Traps: Considerations for Dual-Class Companies Contemplating M&A Transactions

Cooley M&A

There are compelling rationales for adopting a dual-class structure, but even proponents of the structure generally acknowledge that these benefits are significantly mitigated once the dual-class shares are out of the hands of the founders and/or pre-IPO stockholders. Potential carve outs for M&A voting agreements.

M&A 59
article thumbnail

Active UK corporate venture capital firms

Growth Business

Unlike standard venture capital firms, CVCs work a lot closer with their portfolio companies in developing a particular technology that is beneficial to both parties. It is interested in companies at pre-Series A through to pre-IPO stage. Here, we list active CVCs in the UK, what they look for and how much they invest.